Detection of novel biomarkers for ovarian cancer with an optical nanotechnology detection system enabling label-free diagnostics
- 14 June 2012
- journal article
- Published by SPIE-Intl Soc Optical Eng in Journal of Biomedical Optics
- Vol. 17 (8) , 0814121-0814128
Abstract
Ovarian carcinoma has the highest lethality rate of gynecologic tumors, largely attributed to the late-stage diagnosis of the disease. Reliable tools for both accurate diagnosis and early detection of disease onset are lacking, and presently less than 20% of ovarian cancers are detected at an early stage. Protein biomarkers that allow the discrimination of early and late stages of ovarian serous carcinomas are urgently needed as they would enable monitoring pre-symptomatic aspects of the disease, disease progression, and the efficacy of intervention therapies. We compare the absolute and relative protein levels of six protein biomarkers for ovarian cancer in five different established ovarian cancer cell lines, utilizing both quantitative immunoblot analysis and a guided-mode resonance (GMR) bioassay detection system that utilizes a label-free optical biosensor readout. The GMR sensor approach provided highly accurate, consistent, and reproducible quantification of protein biomarkers as validated by quantitative immunoblotting, as well as enhanced sensitivity, and is therefore suitable for quantification and detection of novel biomarkers for ovarian cancer. We identified fibronectin, apolipoprotein A1, and TIMP3 as potential protein biomarkers for the differential diagnosis of primary versus metastatic ovarian carcinoma. Future studies are needed to confirm the suitability of protein biomarkers tested herein in patient samples.Keywords
Funding Information
- NIH SBIR (R43CA135960)
- NSF SBIR (0724407)
This publication has 54 references indexed in Scilit:
- Resonant Photonic Biosensors with Polarization-Based Multiparametric Discrimination in Each ChannelSensors, 2011
- Senescent Peritoneal Mesothelial Cells Promote Ovarian Cancer Cell AdhesionThe American Journal of Pathology, 2009
- A disintegrin and metalloprotease 21 (ADAM21) is associated with neurogenesis and axonal growth in developing and adult rodent CNSJournal of Comparative Neurology, 2005
- Tunicamycin induces ubiquitination and degradation of apolipoprotein B in HepG2 cellsBiochemical Journal, 2001
- Novel Homologues of CSBP/p38 MAP Kinase: Activation, Substrate Specificity and Sensitivity to Inhibition by Pyridinyl ImidazolesBiochemical and Biophysical Research Communications, 1997
- Requirement of Calmodulindependent Protein Kinase II in Cyclic ADP-ribose-mediated Intracellular Ca2+ MobilizationJournal of Biological Chemistry, 1995
- A MAP Kinase Targeted by Endotoxin and Hyperosmolarity in Mammalian CellsScience, 1994
- Cloning and Characterization of Human Tissue Inhibitor of Metalloproteinases-3DNA and Cell Biology, 1994
- Glucocorticoids Stabilize HER-2/neu Messenger RNA in Human Epithelial Ovarian Carcinoma CellsGynecologic Oncology, 1994
- Development of monoclonal antibodies to collagens for assesing host?implant interactionsJournal of Biomedical Materials Research, 1989